02 January 2024 | Mei Zhao, Tianxiao Wang, Frederico O. Gleber-Netto, Zhen Chen, Daniel J. McGrail, Javier A. Gomez, Wutong Ju, Mayur A. Gadhikar, Wencai Ma, Li Shen, Qi Wang, Ximing Tang, Sen Pathak, Maria Gabriela Raso, Jared K. Burks, Shiaw-Yih Lin, Jing Wang, Asha S. Multani, Curtis R. Pickering, Junjie Chen, Jeffrey N. Myers, Ge Zhou
The study investigates the oncogenic functions of mutant p53 (mutp53) proteins, which can promote tumor development and progression despite their loss-of-function (LOF) effects. The researchers found that mutp53 interacts with minichromosome maintenance complex components (MCMs), leading to replication stress and chromosomal instability (CIN). This CIN triggers a tumor cell-intrinsic cytosolic DNA response, activating the cGAS-STING pathway and downstream non-canonical nuclear factor kappa light chain enhancer of activated B cell (NC-NF-κB) signaling. This signaling pathway promotes tumor metastasis and an immunosuppressive tumor microenvironment by antagonizing interferon (IFN) signaling and regulating genes associated with pro-tumorigenic inflammation. The findings highlight the importance of CIN in mutp53-induced oncogenic phenotypes and suggest that targeting the NC-NF-κB signaling pathway could be a potential therapeutic strategy for cancers with TP53 inactivation-induced CIN.The study investigates the oncogenic functions of mutant p53 (mutp53) proteins, which can promote tumor development and progression despite their loss-of-function (LOF) effects. The researchers found that mutp53 interacts with minichromosome maintenance complex components (MCMs), leading to replication stress and chromosomal instability (CIN). This CIN triggers a tumor cell-intrinsic cytosolic DNA response, activating the cGAS-STING pathway and downstream non-canonical nuclear factor kappa light chain enhancer of activated B cell (NC-NF-κB) signaling. This signaling pathway promotes tumor metastasis and an immunosuppressive tumor microenvironment by antagonizing interferon (IFN) signaling and regulating genes associated with pro-tumorigenic inflammation. The findings highlight the importance of CIN in mutp53-induced oncogenic phenotypes and suggest that targeting the NC-NF-κB signaling pathway could be a potential therapeutic strategy for cancers with TP53 inactivation-induced CIN.